This document is includes information on WHO position on pneumococcal vaccines in infants in children; vaccine characteristics; safety; PCV performance; programmatic considerations; cost and...
The Global Health Expenditure Database (GHED) provides comparable data on health expenditure for 192 countries over the past 20 years. Health spending indicators are key guides for monitoring...
Palestinian Ministry of Health, Rostropovich-Vishnevskaya Foundation, PATH
Rotavirus vaccination in Palestine has significantly reduced the burden of diarrhea among children, and the benefits were sustained through a vaccine product switch.
In 2018, the Palestinian...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on...
Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.
This brief describes an...
In November 2020, WHO-UNICEF “Guidance on developing a national deployment and vaccination plan (NDVP)” for COVID-19 vaccines was issued to support countries to develop their national strategies....
There are few interventions targeting young adolescents and those that do exist are often not adequately reaching them. This is because the number of contacts between the health system and...
In accordance with its mandate to provide
guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines
and combinations of vaccines...
In accordance with its mandate to provide
guidance to Member States on health
policy matters, WHO issues a series of
regularly updated position papers
on vaccines and combinations of...
National governments require economic data on the burden of influenza disease, the cost effectiveness of the vaccine, and the projected implementation costs of a maternal influenza immunization...
WHO has developed an introduction manual for national immunization programme managers and policy-makers to support the introduction of influenza immunization of pregnant women.
This document aims...
WHO has developed an introduction manual for national immunization programme managers and policy-makers to support the introduction of health worker influenza immunization.
In order to assist UN country teams in scaling up country preparedness and response to COVID-19, WHO has developed these learning modules as a companion to the Operational Planning Guidelines to...
As a public health emergency of international concern, the COVID-19 pandemic (caused by the novel SARS-CoV-2 virus) has drawn global attention and response. As of 19 March 2020, 51 of 53 countries in...
Immunization is an essential health service which may be affected by the current COVID-19 pandemic. Disruption of immunization services, even for brief periods, will result in increased numbers of...
This updated position paper on yellow fever (YF) vaccines and vaccination replaces the previous 2003 WHO position paper and summarizes recent developments in the field. Recommendations on the ...
This position paper replaces the previous 2006 WHO position paper on tetanus toxoid (TT) vaccines. It incorporates recent developments in the field of tetanus prevention and provides revised...
This position paper replaces the 2013 WHO position paper on rotavirus vaccines; it adds recent developments in the field, such as 2 additional rotavirus vaccines prequalified by WHO in 2018, as well...
This position paper replaces the 2010 WHO position on rabies vaccines.1 It pres-ents new evidence in the field of rabies and the use of rabies vaccines, focussing on...
This guidance note for National Immunization Programmes aims to:
Present considerations regarding the involvement of nongovernmental (private) providers in vaccine delivery (including...
A 23-valent polysaccharide vaccine has been available
since the early 1980s, and pneumococcal conjugate
vaccines (PCV) have been available since 2009. The focus of this position paper is use of PCV...
This updated document provides guidance to countries to make national comprehensive multi-year strategic plans (cMYP) for immunization, using the Global Vaccine Action Plan (GVAP) 2011-2020 as a...
The main revisions in this position paper concern the guidance on the choice of pertussis vaccine – whole cell pertussis (wP) or acellular pertussis (aP) vaccine – reflecting the...
The purpose of this document is to make the most economical and effective use of resources, in order to ensure the development of high quality, evidence-informed recommendations Document dedicated to...
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against...
This document incorporates the most recent developments in the field of meningococcal vaccines to guide the introduction and use of meningococcal vaccines in national immunization schedules....
This document replaces the first rubella
vaccine position paper published in the
Weekly Epidemiological Record in May
2000.2 It incorporates the most recent developments
in the field of rubella...
This position paper incorporates the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine...
WHO recommends that Haemophilus influenzae type B (Hib) vaccine be included in routine infant immunization programmes for all children, as appropriate to national capacities and priorities. This...
The main objective of this tool is to provide a methodology for countries to rapidly assess the burden of Hib disease using as much local data as possible. This document includes information on how...
This updated position paper on Haemophilus
influenzae type b (Hib) vaccines
replaces the previous 2006 WHO position
paper, and summarizes recent developments
in the field. Recommendations on
the...
The Guide is written for those responsible for, or those who advise on, the development and improvement of health financing policies. The intention is to not to prescribe a process or particular...
This position paper replaces the 2006 WHO position paper on diphtheria vaccine. It incorporates recent evidence on diphtheria and provides revised recommendations on the optimal number of doses...
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against...
This position paper replaces the 2010 WHO position paper on cholera vaccines. It incorporates recent developments in the field of cholera and provides revised guidance on the target populations for...
This guidance\'s objectives are to: 1. Raise the level of awareness and contribute to capacity building on issues associated with decommissioning and disposal by providing an overview of CCE...
The purpose of this document is to provide World Health Organization (WHO)-recommended standards for conducting surveillance for vaccine preventable diseases (VPDs). VPD surveillance provides vital...
There is a continuing high burden of typhoid fever in many parts of the world and a rapid increase in the emergence and spread of antimicrobial resistant strains of S. Typhi. Currently available...
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations against...
This document replaces the 2009 WHO position paper on hepatitis B vaccines. It provides updated information on hepatitis B vaccines and their storage, transport and deployment. The recommendations...
This document replaces the 2014 WHO position paper on vaccines against diseases caused by human papillomaviruses (HPV). It focuses primarily on the prevention of cervical cancer, ...
This is the first WHO position paper on a dengue vaccine. It focuses primarily on the available evidence concerning the only dengue vaccine to have been registered by National Regulatory Authorities...
On the initiative of the Latin American and Caribbean Network for Strengthening Health Information Systems (RELACSIS), a group of 200 people enrolled in a virtual forum where they discussed the...
This decision-framework document aims to provide an approach for deciding which vaccines, if pre-emptively and properly delivered at the outset of an emergency, would constitute high priority...
Esta guía práctica pretende ayudar a los gestores de salud pública a planificar la implementación de tecnologías de la información y las comunicaciones (TIC) a los sistemas de información...
PATH and London School of Hygiene & Tropical Medicine
To aid decision-makers interested in human papillomavirus (HPV) vaccine introduction or scale-up, the London School of Hygiene & Tropical Medicine and PATH completed the first comprehensive review of...
Plan de Acción Mundial sobre Vacunas ( GVAP ) - aprobada por los 194 Estados miembros de la Asamblea Mundial de la Salud en mayo de 2012 - es un marco para evitar la prevención de muertes millón...
An EPI Review, also referred to as National Immunization Programme Review, is the comprehensive assessment of the strengths and weaknesses of an immunization programme at national, subnational and...
São apresentadas diferentes experiências e metodologias empregadas por registros informatizados de imunização (RII), no enfoque da saúde infantil. O levantamento bibliográfico abrangeu...